The global market for Leukemia Targeted Therapy Drugs was valued at US$ 4126 million in the year 2023 and is projected to reach a revised size of US$ 6245 million by 2030, growing at a CAGR of 6.1% during the forecast period.

Leukemia Targeted Therapy Drugs Market

Leukemia targeted therapy drugs are specialized medications designed to treat leukemia by specifically targeting the molecular and genetic abnormalities that drive the growth of cancer cells. Unlike traditional chemotherapy, which affects both healthy and cancerous cells, targeted therapies focus on mechanisms such as inhibiting tyrosine kinases, blocking abnormal protein functions, or interfering with the cancer cell's ability to grow and divide. Common drugs include tyrosine kinase inhibitors like imatinib for chronic myeloid leukemia (CML) and monoclonal antibodies targeting specific leukemia markers. These therapies improve treatment outcomes by offering greater precision, fewer side effects, and enhanced efficacy, especially in patients with specific genetic mutations or biomarkers.

North American market for Leukemia Targeted Therapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Leukemia Targeted Therapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Leukemia Targeted Therapy Drugs in Acute Myeloid Leukemia (AML) is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Leukemia Targeted Therapy Drugs include Novartis Pharms, Bristol-Myers Squibb, IL-Yang Pharms, Pfizer, Takeda Oncology, Johnson & Johnson, Gilead Sciences, Abbvie, Genentech, Sanofi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Leukemia Targeted Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leukemia Targeted Therapy Drugs.

The Leukemia Targeted Therapy Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Leukemia Targeted Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Leukemia Targeted Therapy Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Leukemia Targeted Therapy Drugs Market Report

Report Metric	Details
Report Name	Leukemia Targeted Therapy Drugs Market
Accounted market size in year	US$ 4126 million
Forecasted market size in 2030	US$ 6245 million
CAGR	6.1%
Base Year	year
Forecasted years	2024 - 2030
Segment by Type	Monoclonal Antibodies Small-Molecule Drugs
Segment by Application	Acute Myeloid Leukemia (AML) Chronic Myeloid Leukemia (CML) Acute Lymphoblastic Leukemia (ALL) Chronic Lymphocytic Leukemia (CLL)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis Pharms, Bristol-Myers Squibb, IL-Yang Pharms, Pfizer, Takeda Oncology, Johnson & Johnson, Gilead Sciences, Abbvie, Genentech, Sanofi, Amgen, Roche, GlaxoSmithKline, AstraZeneca, BeiGene, Eli Lilly, Merck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leukemia Targeted Therapy Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Leukemia Targeted Therapy Drugs Market growing?

Ans: The Leukemia Targeted Therapy Drugs Market witnessing a CAGR of 6.1% during the forecast period 2024-2030.

What is the Leukemia Targeted Therapy Drugs Market size in 2030?

Ans: The Leukemia Targeted Therapy Drugs Market size in 2030 will be US$ 6245 million.

Who are the main players in the Leukemia Targeted Therapy Drugs Market report?

Ans: The main players in the Leukemia Targeted Therapy Drugs Market are Novartis Pharms, Bristol-Myers Squibb, IL-Yang Pharms, Pfizer, Takeda Oncology, Johnson & Johnson, Gilead Sciences, Abbvie, Genentech, Sanofi, Amgen, Roche, GlaxoSmithKline, AstraZeneca, BeiGene, Eli Lilly, Merck

What are the Application segmentation covered in the Leukemia Targeted Therapy Drugs Market report?

Ans: The Applications covered in the Leukemia Targeted Therapy Drugs Market report are Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL)

What are the Type segmentation covered in the Leukemia Targeted Therapy Drugs Market report?

Ans: The Types covered in the Leukemia Targeted Therapy Drugs Market report are Monoclonal Antibodies, Small-Molecule Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Leukemia Targeted Therapy Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Monoclonal Antibodies

1.2.3 Small-Molecule Drugs

1.3 Market by Application

1.3.1 Global Leukemia Targeted Therapy Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Acute Myeloid Leukemia (AML)

1.3.3 Chronic Myeloid Leukemia (CML)

1.3.4 Acute Lymphoblastic Leukemia (ALL)

1.3.5 Chronic Lymphocytic Leukemia (CLL)

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Leukemia Targeted Therapy Drugs Market Perspective (2019-2030)

2.2 Global Leukemia Targeted Therapy Drugs Growth Trends by Region

2.2.1 Global Leukemia Targeted Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Leukemia Targeted Therapy Drugs Historic Market Size by Region (2019-2024)

2.2.3 Leukemia Targeted Therapy Drugs Forecasted Market Size by Region (2025-2030)

2.3 Leukemia Targeted Therapy Drugs Market Dynamics

2.3.1 Leukemia Targeted Therapy Drugs Industry Trends

2.3.2 Leukemia Targeted Therapy Drugs Market Drivers

2.3.3 Leukemia Targeted Therapy Drugs Market Challenges

2.3.4 Leukemia Targeted Therapy Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Leukemia Targeted Therapy Drugs Players by Revenue

3.1.1 Global Top Leukemia Targeted Therapy Drugs Players by Revenue (2019-2024)

3.1.2 Global Leukemia Targeted Therapy Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Leukemia Targeted Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Leukemia Targeted Therapy Drugs Revenue

3.4 Global Leukemia Targeted Therapy Drugs Market Concentration Ratio

3.4.1 Global Leukemia Targeted Therapy Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Leukemia Targeted Therapy Drugs Revenue in 2023

3.5 Global Key Players of Leukemia Targeted Therapy Drugs Head office and Area Served

3.6 Global Key Players of Leukemia Targeted Therapy Drugs, Product and Application

3.7 Global Key Players of Leukemia Targeted Therapy Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Leukemia Targeted Therapy Drugs Breakdown Data by Type

4.1 Global Leukemia Targeted Therapy Drugs Historic Market Size by Type (2019-2024)

4.2 Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Type (2025-2030)

5 Leukemia Targeted Therapy Drugs Breakdown Data by Application

5.1 Global Leukemia Targeted Therapy Drugs Historic Market Size by Application (2019-2024)

5.2 Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Leukemia Targeted Therapy Drugs Market Size (2019-2030)

6.2 North America Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024)

6.4 North America Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Leukemia Targeted Therapy Drugs Market Size (2019-2030)

7.2 Europe Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024)

7.4 Europe Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Leukemia Targeted Therapy Drugs Market Size (2019-2030)

8.2 Asia-Pacific Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Leukemia Targeted Therapy Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Leukemia Targeted Therapy Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Leukemia Targeted Therapy Drugs Market Size (2019-2030)

9.2 Latin America Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024)

9.4 Latin America Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Leukemia Targeted Therapy Drugs Market Size (2019-2030)

10.2 Middle East & Africa Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis Pharms

11.1.1 Novartis Pharms Company Details

11.1.2 Novartis Pharms Business Overview

11.1.3 Novartis Pharms Leukemia Targeted Therapy Drugs Introduction

11.1.4 Novartis Pharms Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.1.5 Novartis Pharms Recent Development

11.2 Bristol-Myers Squibb

11.2.1 Bristol-Myers Squibb Company Details

11.2.2 Bristol-Myers Squibb Business Overview

11.2.3 Bristol-Myers Squibb Leukemia Targeted Therapy Drugs Introduction

11.2.4 Bristol-Myers Squibb Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.2.5 Bristol-Myers Squibb Recent Development

11.3 IL-Yang Pharms

11.3.1 IL-Yang Pharms Company Details

11.3.2 IL-Yang Pharms Business Overview

11.3.3 IL-Yang Pharms Leukemia Targeted Therapy Drugs Introduction

11.3.4 IL-Yang Pharms Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.3.5 IL-Yang Pharms Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Leukemia Targeted Therapy Drugs Introduction

11.4.4 Pfizer Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.4.5 Pfizer Recent Development

11.5 Takeda Oncology

11.5.1 Takeda Oncology Company Details

11.5.2 Takeda Oncology Business Overview

11.5.3 Takeda Oncology Leukemia Targeted Therapy Drugs Introduction

11.5.4 Takeda Oncology Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.5.5 Takeda Oncology Recent Development

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Details

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Leukemia Targeted Therapy Drugs Introduction

11.6.4 Johnson & Johnson Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.6.5 Johnson & Johnson Recent Development

11.7 Gilead Sciences

11.7.1 Gilead Sciences Company Details

11.7.2 Gilead Sciences Business Overview

11.7.3 Gilead Sciences Leukemia Targeted Therapy Drugs Introduction

11.7.4 Gilead Sciences Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.7.5 Gilead Sciences Recent Development

11.8 Abbvie

11.8.1 Abbvie Company Details

11.8.2 Abbvie Business Overview

11.8.3 Abbvie Leukemia Targeted Therapy Drugs Introduction

11.8.4 Abbvie Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.8.5 Abbvie Recent Development

11.9 Genentech

11.9.1 Genentech Company Details

11.9.2 Genentech Business Overview

11.9.3 Genentech Leukemia Targeted Therapy Drugs Introduction

11.9.4 Genentech Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.9.5 Genentech Recent Development

11.10 Sanofi

11.10.1 Sanofi Company Details

11.10.2 Sanofi Business Overview

11.10.3 Sanofi Leukemia Targeted Therapy Drugs Introduction

11.10.4 Sanofi Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.10.5 Sanofi Recent Development

11.11 Amgen

11.11.1 Amgen Company Details

11.11.2 Amgen Business Overview

11.11.3 Amgen Leukemia Targeted Therapy Drugs Introduction

11.11.4 Amgen Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.11.5 Amgen Recent Development

11.12 Roche

11.12.1 Roche Company Details

11.12.2 Roche Business Overview

11.12.3 Roche Leukemia Targeted Therapy Drugs Introduction

11.12.4 Roche Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.12.5 Roche Recent Development

11.13 GlaxoSmithKline

11.13.1 GlaxoSmithKline Company Details

11.13.2 GlaxoSmithKline Business Overview

11.13.3 GlaxoSmithKline Leukemia Targeted Therapy Drugs Introduction

11.13.4 GlaxoSmithKline Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.13.5 GlaxoSmithKline Recent Development

11.14 AstraZeneca

11.14.1 AstraZeneca Company Details

11.14.2 AstraZeneca Business Overview

11.14.3 AstraZeneca Leukemia Targeted Therapy Drugs Introduction

11.14.4 AstraZeneca Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.14.5 AstraZeneca Recent Development

11.15 BeiGene

11.15.1 BeiGene Company Details

11.15.2 BeiGene Business Overview

11.15.3 BeiGene Leukemia Targeted Therapy Drugs Introduction

11.15.4 BeiGene Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.15.5 BeiGene Recent Development

11.16 Eli Lilly

11.16.1 Eli Lilly Company Details

11.16.2 Eli Lilly Business Overview

11.16.3 Eli Lilly Leukemia Targeted Therapy Drugs Introduction

11.16.4 Eli Lilly Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.16.5 Eli Lilly Recent Development

11.17 Merck

11.17.1 Merck Company Details

11.17.2 Merck Business Overview

11.17.3 Merck Leukemia Targeted Therapy Drugs Introduction

11.17.4 Merck Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024)

11.17.5 Merck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Leukemia Targeted Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Small-Molecule Drugs

Table 4. Global Leukemia Targeted Therapy Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Leukemia Targeted Therapy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Leukemia Targeted Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Leukemia Targeted Therapy Drugs Market Share by Region (2019-2024)

Table 8. Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Leukemia Targeted Therapy Drugs Market Share by Region (2025-2030)

Table 10. Leukemia Targeted Therapy Drugs Market Trends

Table 11. Leukemia Targeted Therapy Drugs Market Drivers

Table 12. Leukemia Targeted Therapy Drugs Market Challenges

Table 13. Leukemia Targeted Therapy Drugs Market Restraints

Table 14. Global Leukemia Targeted Therapy Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Leukemia Targeted Therapy Drugs Market Share by Players (2019-2024)

Table 16. Global Top Leukemia Targeted Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Targeted Therapy Drugs as of 2023)

Table 17. Ranking of Global Top Leukemia Targeted Therapy Drugs Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Leukemia Targeted Therapy Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Leukemia Targeted Therapy Drugs, Headquarters and Area Served

Table 20. Global Key Players of Leukemia Targeted Therapy Drugs, Product and Application

Table 21. Global Key Players of Leukemia Targeted Therapy Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Leukemia Targeted Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Type (2019-2024)

Table 25. Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Type (2025-2030)

Table 27. Global Leukemia Targeted Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Application (2019-2024)

Table 29. Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Application (2025-2030)

Table 31. North America Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Leukemia Targeted Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Leukemia Targeted Therapy Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Leukemia Targeted Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Leukemia Targeted Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 46. Novartis Pharms Company Details

Table 47. Novartis Pharms Business Overview

Table 48. Novartis Pharms Leukemia Targeted Therapy Drugs Product

Table 49. Novartis Pharms Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 50. Novartis Pharms Recent Development

Table 51. Bristol-Myers Squibb Company Details

Table 52. Bristol-Myers Squibb Business Overview

Table 53. Bristol-Myers Squibb Leukemia Targeted Therapy Drugs Product

Table 54. Bristol-Myers Squibb Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 55. Bristol-Myers Squibb Recent Development

Table 56. IL-Yang Pharms Company Details

Table 57. IL-Yang Pharms Business Overview

Table 58. IL-Yang Pharms Leukemia Targeted Therapy Drugs Product

Table 59. IL-Yang Pharms Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 60. IL-Yang Pharms Recent Development

Table 61. Pfizer Company Details

Table 62. Pfizer Business Overview

Table 63. Pfizer Leukemia Targeted Therapy Drugs Product

Table 64. Pfizer Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 65. Pfizer Recent Development

Table 66. Takeda Oncology Company Details

Table 67. Takeda Oncology Business Overview

Table 68. Takeda Oncology Leukemia Targeted Therapy Drugs Product

Table 69. Takeda Oncology Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 70. Takeda Oncology Recent Development

Table 71. Johnson & Johnson Company Details

Table 72. Johnson & Johnson Business Overview

Table 73. Johnson & Johnson Leukemia Targeted Therapy Drugs Product

Table 74. Johnson & Johnson Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 75. Johnson & Johnson Recent Development

Table 76. Gilead Sciences Company Details

Table 77. Gilead Sciences Business Overview

Table 78. Gilead Sciences Leukemia Targeted Therapy Drugs Product

Table 79. Gilead Sciences Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 80. Gilead Sciences Recent Development

Table 81. Abbvie Company Details

Table 82. Abbvie Business Overview

Table 83. Abbvie Leukemia Targeted Therapy Drugs Product

Table 84. Abbvie Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 85. Abbvie Recent Development

Table 86. Genentech Company Details

Table 87. Genentech Business Overview

Table 88. Genentech Leukemia Targeted Therapy Drugs Product

Table 89. Genentech Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 90. Genentech Recent Development

Table 91. Sanofi Company Details

Table 92. Sanofi Business Overview

Table 93. Sanofi Leukemia Targeted Therapy Drugs Product

Table 94. Sanofi Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 95. Sanofi Recent Development

Table 96. Amgen Company Details

Table 97. Amgen Business Overview

Table 98. Amgen Leukemia Targeted Therapy Drugs Product

Table 99. Amgen Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 100. Amgen Recent Development

Table 101. Roche Company Details

Table 102. Roche Business Overview

Table 103. Roche Leukemia Targeted Therapy Drugs Product

Table 104. Roche Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 105. Roche Recent Development

Table 106. GlaxoSmithKline Company Details

Table 107. GlaxoSmithKline Business Overview

Table 108. GlaxoSmithKline Leukemia Targeted Therapy Drugs Product

Table 109. GlaxoSmithKline Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 110. GlaxoSmithKline Recent Development

Table 111. AstraZeneca Company Details

Table 112. AstraZeneca Business Overview

Table 113. AstraZeneca Leukemia Targeted Therapy Drugs Product

Table 114. AstraZeneca Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 115. AstraZeneca Recent Development

Table 116. BeiGene Company Details

Table 117. BeiGene Business Overview

Table 118. BeiGene Leukemia Targeted Therapy Drugs Product

Table 119. BeiGene Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 120. BeiGene Recent Development

Table 121. Eli Lilly Company Details

Table 122. Eli Lilly Business Overview

Table 123. Eli Lilly Leukemia Targeted Therapy Drugs Product

Table 124. Eli Lilly Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 125. Eli Lilly Recent Development

Table 126. Merck Company Details

Table 127. Merck Business Overview

Table 128. Merck Leukemia Targeted Therapy Drugs Product

Table 129. Merck Revenue in Leukemia Targeted Therapy Drugs Business (2019-2024) & (US$ Million)

Table 130. Merck Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Leukemia Targeted Therapy Drugs Picture

Figure 2. Global Leukemia Targeted Therapy Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Leukemia Targeted Therapy Drugs Market Share by Type: 2023 VS 2030

Figure 4. Monoclonal Antibodies Features

Figure 5. Small-Molecule Drugs Features

Figure 6. Global Leukemia Targeted Therapy Drugs Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global Leukemia Targeted Therapy Drugs Market Share by Application: 2023 VS 2030

Figure 8. Acute Myeloid Leukemia (AML) Case Studies

Figure 9. Chronic Myeloid Leukemia (CML) Case Studies

Figure 10. Acute Lymphoblastic Leukemia (ALL) Case Studies

Figure 11. Chronic Lymphocytic Leukemia (CLL) Case Studies

Figure 12. Leukemia Targeted Therapy Drugs Report Years Considered

Figure 13. Global Leukemia Targeted Therapy Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Leukemia Targeted Therapy Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Leukemia Targeted Therapy Drugs Market Share by Region: 2023 VS 2030

Figure 16. Global Leukemia Targeted Therapy Drugs Market Share by Players in 2023

Figure 17. Global Top Leukemia Targeted Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Targeted Therapy Drugs as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Leukemia Targeted Therapy Drugs Revenue in 2023

Figure 19. North America Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Leukemia Targeted Therapy Drugs Market Share by Country (2019-2030)

Figure 21. United States Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Leukemia Targeted Therapy Drugs Market Share by Country (2019-2030)

Figure 25. Germany Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Leukemia Targeted Therapy Drugs Market Share by Region (2019-2030)

Figure 33. China Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Leukemia Targeted Therapy Drugs Market Share by Country (2019-2030)

Figure 41. Mexico Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Leukemia Targeted Therapy Drugs Market Share by Country (2019-2030)

Figure 45. Turkey Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. UAE Leukemia Targeted Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Novartis Pharms Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 50. IL-Yang Pharms Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 51. Pfizer Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 52. Takeda Oncology Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 53. Johnson & Johnson Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 54. Gilead Sciences Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 55. Abbvie Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 56. Genentech Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 57. Sanofi Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 58. Amgen Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 59. Roche Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 60. GlaxoSmithKline Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 61. AstraZeneca Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 62. BeiGene Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 63. Eli Lilly Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 64. Merck Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions